TargetMol

Syn-Ake acetate

Product Code:
 
TAR-T7895
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T7895-1mg1mg£116.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7895-2mg2mg£141.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7895-5mg5mg£179.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7895-10mg10mg£230.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7895-25mg25mg£365.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7895-50mg50mg£511.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7895-100mg100mg£704.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Syn-Ake acetate is a muscarinic acetylcholine receptor antagonist.
CAS:
823202-99-9
Formula:
C23H37N5O7
Molecular Weight:
495.577
Pathway:
Neuroscience
Purity:
0.9879
SMILES:
CC(O)=O.CC(O)=O.NCCC(NC(=O)C1CCCN1C(=O)CCN)C(=O)NCc1ccccc1
Target:
AChR

References

Balaev A N , Okhmanovich K A , Osipov V N . A shortened, protecting group free, synthesis of the anti-wrinkle venom analogue Syn-Ake? exploiting an optimized Hofmann-type rearrangement[J]. Tetrahedron Letters, 2014, 55(42):5745-5747.